Avalyn Pharma
Develops inhaled therapies for rare respiratory diseases.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2011
- Employees
- 59
- Headquarters
- United States
- Type
- Private
- Funding
- Series D · $100M · 2025
Develops inhaled therapies for rare respiratory diseases.
Company facts